Business Club November 12th News October 29th, Lin Jianning, director of the SFDA Southern Medicine Economic Research Institute, released the medical economy of this year. In 2010, in the context of a steady growth in the total output value of the pharmaceutical industry, a steady increase in the purchase and sales of pharmaceuticals, and a gradual increase in business concentration, the performance of the pharmaceutical retail market is that the market scale has expanded and the number of retail enterprises has continued to increase. According to the SFDA Southern China Drug Retail Analysis System, the pharmaceutical retail market in 2009 was 148.7 billion yuan, an increase of approximately 14.8% year-on-year; the pharmaceutical retail market in 2010 was approximately 179.3 billion yuan, an increase of 17% year-on-year. According to the analysis, the growth rate recovery benefited from the expansion of medical insurance coverage and the improvement of consumers' self-medication level.
As of the end of 2009, the total number of pharmacies in China (including chain stores and monomer pharmacies) was 381,371, an increase of 4.32% year-on-year; in the first half of 2010, China had 394,200 retail pharmacies, which increased by 3.27%. From the increase in the number of pharmacies, the growth rate has slowed down.
Also worthy of attention of the retail pharmacy industry is that according to the “Study on China's Pharmaceutical Economic Operational Analysis System†by the Southern Institute of Science and Technology, China has established a total of 544,000 rural pharmaceutical supply outlets and a total of 28,000 community health service centers (stations) and township hospitals. 38,000, but the progress of the implementation of the basic drug system is slow, and with the implementation of the co-ordination of large urban hospitals, the increase in drug consumption in community medical institutions is lower than expected.
For the prediction of the pharmaceutical economy next year, Lin Jianning believes in the report that the growth rate of GDP will be no less than 8%, the world economy will not experience double bottoming, and the 850 billion increase in investment will be able to meet the three conditions of progress. The pharmaceutical industry in 2011 It will maintain a high growth rate, and the increase will be slightly higher than this year; in addition, with the increase in medical reform investment, the drug market in 2011 will further expand; the implementation of a series of policies such as drug price bidding will change the market structure; it is worth attention Also, with the implementation of new GMP, new Pharmacopoeia, and new energy-saving and emission-reduction policies, the cost of the pharmaceutical industry will increase, the pace of capitalization of the pharmaceutical industry will accelerate, and new funds will become the new driving force for pharmaceutical development next year.
Policy: Building a healthy and orderly market system
Among the many policy factors affecting the retail pharmacy operating performance in 2010, specific measures such as the Twelfth Five-Year Plan, new medical reform and other policy trends, and drug price bidding and the official implementation of the new edition of the Pharmacopoeia will continue to affect the development of the entire pharmacy circle in 2011. The key factor is worth paying attention to all drugstore operators.
In August 2009, the State Council decided that the Ministry of Commerce would be responsible for the management of the pharmaceutical distribution industry. In June 2010, the Ministry of Commerce formally became the competent department of the pharmaceutical distribution industry. Its main responsibilities were to study and formulate development plans, policies, and related standards for the pharmaceutical distribution industry.
When talking about the "12th Five-Year" development plan for the pharmaceutical circulation industry, the Deputy Director of the Department of Market Order of the Ministry of Commerce Wen Zaixing pointed out in the report that accelerating the structural adjustment is the key to the reform and development of the pharmaceutical distribution industry during the "12th Five-Year Plan" period. The main idea of ​​structural adjustment is to guide the government and give full play to the basic role of the market mechanism; the company is the main body of the industrial restructuring; and it plays an intermediary role in the social organizations such as industry associations.
Regarding the promulgation of the Measures for the Administration of Drug Price involving the nerves of managers of all pharmaceutical companies, Luo Yan, Deputy Director of the Price Division of the Price Division of the National Development and Reform Commission, also gave a detailed report at the information conference. She pointed out that at present, the newly revised price management measures have become "Medicine Price Management Measures." The next steps are mainly to adjust the prices of essential medicines, to approve the prices of new medical insurance products, and to adjust prices of already-priced medicines. Regarding the reform of separate pricing policies, Luo Yan said that the current price gap between original research and imitation is gradually reduced; the newly-listed original research drug should be roughly linked to the prices of generic drugs; and the generic drugs already listed should be supported by state policies. , or there is a clear superiority in the quality of the certification of a regulatory agency or an authority, which can be appropriately differentiated from the uniform price.
As for the much-cited new medical improvement program, Professor Li Ling of the China Center for Economic Research of Peking University stated that she is full of confidence in the next step in the promotion of health care reform. "Medical care is a problem for all countries in the world. If we can protect the health of all people fairly with lower costs, it will be a huge achievement. Therefore, China's medical reform is an opportunity to explore the Chinese model." Li Ling At the same time, it is pointed out that the reform of public hospitals is a key part of the entire medical reform, and the results of other reforms need to be based on the reform of public hospitals. The current national basic drug system that is being promoted aims to protect residents from access to cheap, convenient, and safe essential drugs, and it is necessary to improve the drug security system from production, circulation, use, and supervision.
As of the end of 2009, the total number of pharmacies in China (including chain stores and monomer pharmacies) was 381,371, an increase of 4.32% year-on-year; in the first half of 2010, China had 394,200 retail pharmacies, which increased by 3.27%. From the increase in the number of pharmacies, the growth rate has slowed down.
Also worthy of attention of the retail pharmacy industry is that according to the “Study on China's Pharmaceutical Economic Operational Analysis System†by the Southern Institute of Science and Technology, China has established a total of 544,000 rural pharmaceutical supply outlets and a total of 28,000 community health service centers (stations) and township hospitals. 38,000, but the progress of the implementation of the basic drug system is slow, and with the implementation of the co-ordination of large urban hospitals, the increase in drug consumption in community medical institutions is lower than expected.
For the prediction of the pharmaceutical economy next year, Lin Jianning believes in the report that the growth rate of GDP will be no less than 8%, the world economy will not experience double bottoming, and the 850 billion increase in investment will be able to meet the three conditions of progress. The pharmaceutical industry in 2011 It will maintain a high growth rate, and the increase will be slightly higher than this year; in addition, with the increase in medical reform investment, the drug market in 2011 will further expand; the implementation of a series of policies such as drug price bidding will change the market structure; it is worth attention Also, with the implementation of new GMP, new Pharmacopoeia, and new energy-saving and emission-reduction policies, the cost of the pharmaceutical industry will increase, the pace of capitalization of the pharmaceutical industry will accelerate, and new funds will become the new driving force for pharmaceutical development next year.
Policy: Building a healthy and orderly market system
Among the many policy factors affecting the retail pharmacy operating performance in 2010, specific measures such as the Twelfth Five-Year Plan, new medical reform and other policy trends, and drug price bidding and the official implementation of the new edition of the Pharmacopoeia will continue to affect the development of the entire pharmacy circle in 2011. The key factor is worth paying attention to all drugstore operators.
In August 2009, the State Council decided that the Ministry of Commerce would be responsible for the management of the pharmaceutical distribution industry. In June 2010, the Ministry of Commerce formally became the competent department of the pharmaceutical distribution industry. Its main responsibilities were to study and formulate development plans, policies, and related standards for the pharmaceutical distribution industry.
When talking about the "12th Five-Year" development plan for the pharmaceutical circulation industry, the Deputy Director of the Department of Market Order of the Ministry of Commerce Wen Zaixing pointed out in the report that accelerating the structural adjustment is the key to the reform and development of the pharmaceutical distribution industry during the "12th Five-Year Plan" period. The main idea of ​​structural adjustment is to guide the government and give full play to the basic role of the market mechanism; the company is the main body of the industrial restructuring; and it plays an intermediary role in the social organizations such as industry associations.
Regarding the promulgation of the Measures for the Administration of Drug Price involving the nerves of managers of all pharmaceutical companies, Luo Yan, Deputy Director of the Price Division of the Price Division of the National Development and Reform Commission, also gave a detailed report at the information conference. She pointed out that at present, the newly revised price management measures have become "Medicine Price Management Measures." The next steps are mainly to adjust the prices of essential medicines, to approve the prices of new medical insurance products, and to adjust prices of already-priced medicines. Regarding the reform of separate pricing policies, Luo Yan said that the current price gap between original research and imitation is gradually reduced; the newly-listed original research drug should be roughly linked to the prices of generic drugs; and the generic drugs already listed should be supported by state policies. , or there is a clear superiority in the quality of the certification of a regulatory agency or an authority, which can be appropriately differentiated from the uniform price.
As for the much-cited new medical improvement program, Professor Li Ling of the China Center for Economic Research of Peking University stated that she is full of confidence in the next step in the promotion of health care reform. "Medical care is a problem for all countries in the world. If we can protect the health of all people fairly with lower costs, it will be a huge achievement. Therefore, China's medical reform is an opportunity to explore the Chinese model." Li Ling At the same time, it is pointed out that the reform of public hospitals is a key part of the entire medical reform, and the results of other reforms need to be based on the reform of public hospitals. The current national basic drug system that is being promoted aims to protect residents from access to cheap, convenient, and safe essential drugs, and it is necessary to improve the drug security system from production, circulation, use, and supervision.
planting bag grow
Guangzhou Zhongzhinan Supply Chain Co.,Ltd. , https://www.gzzhongzhinan.com